Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Geron Corp (GON.DU)

Compare
1.5600
+0.0020
+(0.13%)
As of 12:30:57 PM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
76,994
76,994
237
596
1,393
Cost of Revenue
1,256
1,256
--
--
--
Gross Profit
75,738
75,738
237
596
--
Operating Expense
249,470
249,470
194,181
139,146
115,392
Operating Income
-173,732
-173,732
-193,944
-138,550
-113,999
Net Non Operating Interest Income Expense
1,103
1,103
9,840
-4,353
-3,213
Other Income Expense
-1,943
-1,943
-23
1,002
1,100
Pretax Income
-174,572
-174,572
-184,127
-141,901
-116,112
Net Income Common Stockholders
-174,572
-174,572
-184,127
-141,901
-116,112
Diluted NI Available to Com Stockholders
-174,572
-174,572
-184,127
-141,901
-116,112
Basic EPS
-0.32
-0.27
-0.32
-0.37
-0.35
Diluted EPS
-0.32
-0.27
-0.32
-0.37
-0.35
Basic Average Shares
628,761.4310
646,033.2470
570,645.4050
380,784.8460
327,631.8140
Diluted Average Shares
628,761.4310
646,033.2470
570,645.4050
380,784.8460
327,631.8140
Total Operating Income as Reported
-173,732
-173,732
-193,944
-138,550
-113,999
Total Expenses
250,726
250,726
194,181
139,146
115,392
Net Income from Continuing & Discontinued Operation
-174,572
-174,572
-184,127
-141,901
-116,112
Normalized Income
-172,865
-172,865
-184,127
-141,901
-116,112
Interest Income
19,607
19,607
18,152
2,529
527
Interest Expense
18,504
18,504
8,312
6,882
3,740
Net Interest Income
1,103
1,103
9,840
-4,353
-3,213
EBIT
-156,068
-156,068
-175,815
-135,019
-112,372
EBITDA
-154,847
-154,847
-174,782
-134,151
-111,589
Reconciled Cost of Revenue
1,256
1,256
--
--
--
Reconciled Depreciation
1,221
1,221
1,033
868
783
Net Income from Continuing Operation Net Minority Interest
-174,572
-174,572
-184,127
-141,901
-116,112
Total Unusual Items Excluding Goodwill
-1,707
-1,707
--
--
--
Total Unusual Items
-1,707
-1,707
--
--
--
Normalized EBITDA
-153,140
-153,140
-174,782
-134,151
-111,589
12/31/2021 - 2/25/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HQ1.MU Oruka Therapeutics Inc. R
9.60
0.00%
 
5KW.F SkinBioTherapeutics plc
0.2160
-2.70%
 
RPD.F Royalty Pharma plc
30.96
+0.55%
 
5CV.MU CureVac NV
2.8900
+0.35%
 
AM6.F Amicus Therapeutics, Inc.
8.40
-1.18%
 
ICY.SG Incyte Corp
64.34
+0.06%
 
600161.SS TIANTAN BIO
19.88
+0.05%
 
1S9.SG Seres Therapeutics Inc
0.6902
+1.77%
 
ISI.F Ionis Pharmaceuticals, Inc.
31.00
-0.06%
 
2H51.DU Ocugen Inc
0.5390
+3.95%